We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Processing Genomic Sequences in Minutes

By Biotechdaily staff writers
Posted on 07 Jul 2005
A new computational tool can divide the work of analyzing biologic data into manageable fragments, so that large data sets can run on many processors simultaneously, solving large-scale problems in minutes, rather than weeks.

Called ScalaBLAST, the tool was developed at the U.S. Department of Energy's Pacific Northwest National Laboratory (PNNL, Richland, WA, USA; www.pnl.gov). PNNL's supercomputer has 1,960 processors, lots of memory, and the ability to tackle large problems. However, without special modifications, software does not run any faster on this computer than it would on a personal computer. In order to speed it up and get answers to complicated biologic questions more quickly, PNNL researchers "parallelized” the software, using Global Arrays, a powerful programming toolkit, by creating algorithms to divide up the work.

PNNL researchers state that ScalaBLAST may be used to process complex genomic sequences, essential to understanding the building blocks of the genome. Now they can manage the large influx of data resulting from new questions that arise during human genome research. Prior to this tool, it took researchers 10 days to analyze one organism. Now, they can analyze 13 organisms within nine hours, making the time-to-solution hundreds of times faster.

"Access to and understanding the pieces of genome sequences will allow researchers to understand the body's cellular machinery and discover clues to some types of cancer,” observed T.P. Straatsma, a PNNL senior research scientist. "And it will help in developing drugs or detection methods to be used for particular diseases.”






Related Links:
PNNL

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
07 Jul 2005  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
07 Jul 2005  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
07 Jul 2005  |   BioResearch